Literature DB >> 20493732

Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis.

Lydia Durant1, Wendy T Watford, Haydeé L Ramos, Arian Laurence, Golnaz Vahedi, Lai Wei, Hayato Takahashi, Hong-Wei Sun, Yuka Kanno, Fiona Powrie, John J O'Shea.   

Abstract

STAT3, an essential transcription factor with pleiotropic functions, plays critical roles in the pathogenesis of autoimmunity. Despite recent data linking STAT3 with inflammatory bowel disease, exactly how it contributes to chronic intestinal inflammation is not known. Using a T cell transfer model of colitis, we found that STAT3 expression in T cells was essential for the induction of both colitis and systemic inflammation. STAT3 was critical in modulating the balance of T helper 17 (Th17) and regulatory T (Treg) cells, as well as in promoting CD4(+) T cell proliferation. We used chromatin immunoprecipitation and massive parallel sequencing (ChIP-Seq) to define the genome-wide targets of STAT3 in CD4(+) T cells. We found that STAT3 bound to multiple genes involved in Th17 cell differentiation, cell activation, proliferation, and survival, regulating both expression and epigenetic modifications. Thus, STAT3 orchestrates multiple critical aspects of T cell function in inflammation and homeostasis. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20493732      PMCID: PMC3148263          DOI: 10.1016/j.immuni.2010.05.003

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  56 in total

Review 1.  Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors.

Authors:  T Hirano; K Ishihara; M Hibi
Journal:  Oncogene       Date:  2000-05-15       Impact factor: 9.867

Review 2.  What does Stat3 do?

Authors:  David E Levy; Chien-kuo Lee
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

3.  c-Jun and c-Fos cooperate with STAT3 in IL-6-induced transactivation of the IL-6 respone element (IRE).

Authors:  J J Schuringa; H Timmer; D Luttickhuizen; E Vellenga; W Kruijer
Journal:  Cytokine       Date:  2001-04-21       Impact factor: 3.861

4.  Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17.

Authors:  Sudeepta Aggarwal; Nico Ghilardi; Ming-Hong Xie; Frederic J de Sauvage; Austin L Gurney
Journal:  J Biol Chem       Date:  2002-11-03       Impact factor: 5.157

5.  Increased expression of interleukin 17 in inflammatory bowel disease.

Authors:  S Fujino; A Andoh; S Bamba; A Ogawa; K Hata; Y Araki; T Bamba; Y Fujiyama
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

6.  Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo.

Authors:  R Atreya; J Mudter; S Finotto; J Müllberg; T Jostock; S Wirtz; M Schütz; B Bartsch; M Holtmann; C Becker; D Strand; J Czaja; J F Schlaak; H A Lehr; F Autschbach; G Schürmann; N Nishimoto; K Yoshizaki; H Ito; T Kishimoto; P R Galle; S Rose-John; M F Neurath
Journal:  Nat Med       Date:  2000-05       Impact factor: 53.440

7.  Novel STAT3 target genes exert distinct roles in the inhibition of mesoderm and endoderm differentiation in cooperation with Nanog.

Authors:  Pierre-Yves Bourillot; Irène Aksoy; Valerie Schreiber; Florence Wianny; Herbert Schulz; Oliver Hummel; Norbert Hubner; Pierre Savatier
Journal:  Stem Cells       Date:  2009-08       Impact factor: 6.277

8.  STAT3 is a negative regulator of granulopoiesis but is not required for G-CSF-dependent differentiation.

Authors:  Chien-kuo Lee; Regina Raz; Ramon Gimeno; Rachel Gertner; Birte Wistinghausen; Kenichi Takeshita; Ronald A DePinho; David E Levy
Journal:  Immunity       Date:  2002-07       Impact factor: 31.745

9.  CIS3/SOCS3/SSI3 plays a negative regulatory role in STAT3 activation and intestinal inflammation.

Authors:  A Suzuki; T Hanada; K Mitsuyama; T Yoshida; S Kamizono; T Hoshino; M Kubo; A Yamashita; M Okabe; K Takeda; S Akira; S Matsumoto; A Toyonaga; M Sata; A Yoshimura
Journal:  J Exp Med       Date:  2001-02-19       Impact factor: 14.307

10.  The AP-1 transcription factor Batf controls T(H)17 differentiation.

Authors:  Barbara U Schraml; Kai Hildner; Wataru Ise; Wan-Ling Lee; Whitney A-E Smith; Ben Solomon; Gurmukh Sahota; Julia Sim; Ryuta Mukasa; Saso Cemerski; Robin D Hatton; Gary D Stormo; Casey T Weaver; John H Russell; Theresa L Murphy; Kenneth M Murphy
Journal:  Nature       Date:  2009-07-05       Impact factor: 49.962

View more
  307 in total

Review 1.  Interleukin-23 and T helper 17-type responses in intestinal inflammation: from cytokines to T-cell plasticity.

Authors:  Peter J Morrison; Sarah J Ballantyne; Marika C Kullberg
Journal:  Immunology       Date:  2011-06-02       Impact factor: 7.397

Review 2.  The role of vitamin D in the FGF23, klotho, and phosphate bone-kidney endocrine axis.

Authors:  Mark R Haussler; G Kerr Whitfield; Ichiro Kaneko; Ryan Forster; Rimpi Saini; Jui-Cheng Hsieh; Carol A Haussler; Peter W Jurutka
Journal:  Rev Endocr Metab Disord       Date:  2012-03       Impact factor: 6.514

3.  Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5.

Authors:  Xiang-Ping Yang; Kamran Ghoreschi; Scott M Steward-Tharp; Jaime Rodriguez-Canales; Jinfang Zhu; John R Grainger; Kiyoshi Hirahara; Hong-Wei Sun; Lai Wei; Golnaz Vahedi; Yuka Kanno; John J O'Shea; Arian Laurence
Journal:  Nat Immunol       Date:  2011-01-30       Impact factor: 25.606

4.  Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation.

Authors:  Ashutosh Chaudhry; Robert M Samstein; Piper Treuting; Yuqiong Liang; Marina C Pils; Jan-Michael Heinrich; Robert S Jack; F Thomas Wunderlich; Jens C Brüning; Werner Müller; Alexander Y Rudensky
Journal:  Immunity       Date:  2011-04-22       Impact factor: 31.745

Review 5.  Regulation of CD4+ T-cell polarization by suppressor of cytokine signalling proteins.

Authors:  Camille A Knosp; James A Johnston
Journal:  Immunology       Date:  2012-02       Impact factor: 7.397

6.  Integration of MicroRNA databases to study MicroRNAs associated with multiple sclerosis.

Authors:  Charlotte Angerstein; Michael Hecker; Brigitte Katrin Paap; Dirk Koczan; Madhan Thamilarasan; Hans-Jürgen Thiesen; Uwe Klaus Zettl
Journal:  Mol Neurobiol       Date:  2012-05-02       Impact factor: 5.590

7.  Therapeutic efficacy of suppressing the Jak/STAT pathway in multiple models of experimental autoimmune encephalomyelitis.

Authors:  Yudong Liu; Andrew T Holdbrooks; Patrizia De Sarno; Amber L Rowse; Lora L Yanagisawa; Braden C McFarland; Laurie E Harrington; Chander Raman; Steffanie Sabbaj; Etty N Benveniste; Hongwei Qin
Journal:  J Immunol       Date:  2013-12-09       Impact factor: 5.422

Review 8.  Genetically engineered mouse models for studying inflammatory bowel disease.

Authors:  Atsushi Mizoguchi; Takahito Takeuchi; Hidetomo Himuro; Toshiyuki Okada; Emiko Mizoguchi
Journal:  J Pathol       Date:  2015-11-14       Impact factor: 7.996

9.  Interleukin-10 Directly Inhibits CD8+ T Cell Function by Enhancing N-Glycan Branching to Decrease Antigen Sensitivity.

Authors:  Logan K Smith; Giselle M Boukhaled; Stephanie A Condotta; Sabrina Mazouz; Jenna J Guthmiller; Rahul Vijay; Noah S Butler; Julie Bruneau; Naglaa H Shoukry; Connie M Krawczyk; Martin J Richer
Journal:  Immunity       Date:  2018-01-23       Impact factor: 31.745

10.  Th9 cell development requires a BATF-regulated transcriptional network.

Authors:  Rukhsana Jabeen; Ritobrata Goswami; Olufolakemi Awe; Aishwarya Kulkarni; Evelyn T Nguyen; Andrea Attenasio; Daniel Walsh; Matthew R Olson; Myung H Kim; Robert S Tepper; Jie Sun; Chang H Kim; Elizabeth J Taparowsky; Baohua Zhou; Mark H Kaplan
Journal:  J Clin Invest       Date:  2013-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.